Posture recognition to reduce the insertable cardiac monitor clinical review burden
Insertable cardiac monitors (ICMs) enable the ambulatory diagnosis of unexplained symptoms associated with cardiac arrhythmias, including tachycardia, bradycardia, and pause/asystole. ICMs continually monitor the subcutaneous electrogram (EGM) and record clips of detected arrhythmias for automatic transmission to an online patient care network (PCN) for clinician review.
Authors
- Dhanunjaya Lakkireddy (ORCID: https://orcid.org/0000-0002-1492-2693)
- Fujian Qu
- Roy S. Gardner (ORCID: https://orcid.org/0000-0002-6792-6671)
- Harish Manyam (ORCID: https://orcid.org/0000-0001-9394-1018)
- Nima Badie (ORCID: https://orcid.org/0000-0001-5971-3011)
- Jesjeet Singh Gill (ORCID: https://orcid.org/0000-0002-1594-0084)
- Rakesh Gopinathannair (ORCID: https://orcid.org/0000-0003-4611-3687)
- Fady Dawoud (ORCID: https://orcid.org/0000-0001-5758-413X)
- Devi G. Nair (ORCID: https://orcid.org/0000-0001-8253-947X)
- Dale Yoo (ORCID: https://orcid.org/0000-0002-6336-7016)
Institutions
- Heart Rhythm Society (US)
- University of Tennessee at Chattanooga (US)
- Danaher (United States) (US)
- Erlanger Health System (US)
- Golden Jubilee National Hospital (GB)
- Abbott (United States) (US)
- Arkansas Biosciences Institute (US)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1016/j.hroo.2025.04.013
- Primary Topic
- Non-Invasive Vital Sign Monitoring
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- Boston Scientific Corporation
- ZOLL Medical Corporation
- Abbott Pharmaceuticals